BXP — Beximco Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £240.90m
- £253.42m
- BDT49.12bn
Beximco Pharma. - Settlement of BSEC Order
Beximco Pharma. - Clarification of Press Commentary
Beximco Pharma. - Results for the year ended 30 June 2025
Brief: Beximco Pharma Q1 Profit After Tax £14.8m
Beximco Pharma. - Notification of Preliminary Results and AGM
Beximco Pharma. - Q3 Financial Results 2025-26
Beximco Pharma. - Half Year Results 2025-26
Beximco Pharma. - Q1 Financial Results 2025-26
Beximco Pharma. - Q3 Financial Results 2024-25
Beximco Pharma. - Financial Results from 1 Jan 25 to 31 Mar 26
RCS - Beximco Pharma. - First patients access affordable CF medicine
Beximco Pharma. - Request of Extension to Publish Financial Results
RCS - Beximco Pharma. - Affordable treatment option for cystic fibrosis
Beximco Pharma. - Update on BSEC Order
Brief: Beximco Pharmaceuticals Denies Corruption Allegations In Covid-19 Vaccine Procurement
Beximco Pharma. - Response to media reports and update on BSEC order
Brief: Beximco Pharmaceuticals Says High Court Directed To Dispose Writ Petition
Beximco Pharma. - Update on BSEC order
Beximco Pharma. - Board Changes